Selector is a Sydney based fund manager. Our team combines deep experience in financial markets with diversity of background and thought. We believe in long-term wealth creation and building lasting relationships with our investors.
We focus on stock selection, the funds are high conviction, concentrated and index unaware. Our aim is to capture real earnings per share growth over the long-term. As a result, the portfolios have low turnover and produce tax effective returns. Our ongoing focus on culture and financial sustainability lends itself to strong ESG outcomes.
Selector has a 20-year track record of outperformance and we continue to seek businesses with leadership qualities, run by competent management teams, underpinned by strong balance sheets and with a focus on capital management.
We are a profitable investment firm, we maintain a strong balance sheet, we have no debt.
Selector’s philosophy is to invest sensibly for the long term. A bottom-up stock selection process is used to identify good businesses selling at a fair price.
As a good business evolves into a great business, its underlying real earnings per share grows. Selector aims to capture as much of this earnings growth as possible over time, since this is what translates into share price appreciation.
We seek businesses with leadership qualities, run by competent management teams, underpinned by strong balance sheets and with a focus on capital management.
Selector Funds Management is a founder owned and led business. We invest alongside our clients in the funds that we run. We are open minded and prepared to explore new avenues. We seek to employ people who act ethically at all times, strive to constantly improve and generate outperformance for our clients.
select peopleOur prioritisation of ethical conduct and operational excellence is the driver of client outperformance.
We believe Culture and ESG are intertwined. We consider them both integral to our assessment of a business. Since inception our in-depth corporate engagement program has been the cornerstone of our in-house research.
Our voting program is the other half of our ESG commitment, all resolutions are documented, researched and voted in-house.
Our ongoing focus on culture and financial sustainability lends itself to strong ESG outcomes. This is evidenced by portfolio emissions significantly lower than index emissions, coupled with outperformance since inception.
The Selector High Conviction Equity Fund invests in businesses listed on the Australian Stock Exchange. Our bottom up stock selection process produces a portfolio of our best ideas. The portfolio is high conviction and index agnostic. These businesses generally sit within the S&P ASX 300 Index, although non-index businesses can be included.
The Selector High Conviction Equity strategy is a wholesale fund and is available only to sophisticated and professional investors.
The Selector Australian Equities Fund* invests in businesses listed on the Australian Stock Exchange. Our bottom up stock selection process produces a portfolio of our best ideas. The portfolio is high conviction and index agnostic. These businesses generally sit within the S&P ASX 300 Index, although non-index businesses can be included.
Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the Responsible Entity for the Selector Australian Equities Fund. Equity Trustees is a subsidiary of EQT Holdings Limited (ABN22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).
In this quarterly, we discuss the qualities that go into the stock selection process in our articles “Founding to flourishing”, “Red flag: Debt”, “The art of letting them run” and “A company’s soul lies in its culture”. We follow this with a collection of portfolio company commentaries flowing from the latest reporting season and explore the cumulative actions of companies that have witnessed a shift in the competitive landscape in our piece “Widening the Gap”. We round out the quarterly with a review of Nanosonics upcoming product CORIS, delve into the popularity of GLP-1 medications and finish with macroeconomic insights following our meeting with a global strategist based in New York.
The High Conviction Monthly Update reviews the composition, performance and attribution for the month.
The Selector Australian Equities Fund* Monthly Update reviews the composition, performance and attribution for the month.